Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin
- 15 October 1990
- Vol. 66 (8), 1697-1702
- https://doi.org/10.1002/1097-0142(19901015)66:8<1697::aid-cncr2820660808>3.0.co;2-g
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Unusual presentation of cis‐platinum NeuropathyNeurology, 1988
- A Rationale for the Use of Melanocortins in Neural InjuryPublished by Springer Science and Business Media LLC ,1988
- Common Epithelial Cancer of the OvaryThe New England Journal of Medicine, 1985
- Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studiesCancer, 1984
- Peripheral sensory neuropathy and cisplatin chemotherapyNeurology, 1984
- Current status of systemic chemotherapy in the treatment of advanced ovarian cancer with emphasis on CHAP-5Radiotherapy and Oncology, 1984
- cis-Platinum-induced hypomagnesemia and peripheral neuropathyGynecologic Oncology, 1983
- Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimenCancer, 1983
- Cis-dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasmsCancer, 1980
- Cisplatin (cis-diamminedichloroplatinum II)Cancer Treatment Reviews, 1979